Scuteri Damiana, Berliocchi Laura, Rombolà Laura, Morrone Luigi Antonio, Tonin Paolo, Bagetta Giacinto, Corasaniti Maria Tiziana
Preclinical and Translational Pharmacology, Department of Pharmacy, Health Science and Nutrition, University of Calabria, Cosenza, Italy.
Department of Health Sciences, University "Magna Graecia" of Catanzaro, Catanzaro, Italy.
Front Pharmacol. 2020 May 8;11:663. doi: 10.3389/fphar.2020.00663. eCollection 2020.
Improved living conditions have induced an increase of lifespan often accompanied by comorbidities, responsible for pain, and by cognitive impairment and dementia, impairing communication capabilities. In most cases, the elderly do not receive pain relief because of underdiagnosis and of aging-induced changes of systems affecting nociceptive response. Unrelieved pain is involved in the development of behavioral symptoms, as agitation, representing a difficult challenge in this fragile population. Aged C57BL/6 mice and amyloid precursor protein (APP) mice display behavioral disturbances that mimic behavioral and psychological symptoms of dementia (BPSD). Therefore, this original study focuses on the influence of aging on nociception to provide insight into the occurrence of BPSD. We have investigated how aging can affect nociception after formalin administration and gabapentin effect in C57BL/6 mice, since it represents one of the treatments of choice for chronic neuropathic pain. Based on our results, changes of nociceptive behavior in response to an algogen stimulus occur during aging. Formalin-induced behavioral pattern in older C57BL/6 mice presents a temporal shift and an increase in the peak amplitudes. Our data show that the effectiveness of gabapentin is influenced by the age of the animal; though preliminary, the latter provide evidence upon which formalin test induced long-lasting mechanical allodynia might be a reliable as rapid and viable persistent pain model. The disclosed differences in effectiveness of gabapentin according to age can form the rational basis to deepen the study of pain treatment in the elderly.
生活条件的改善使寿命延长,但往往伴随着合并症,这些合并症会导致疼痛,还会引起认知障碍和痴呆,损害沟通能力。在大多数情况下,老年人由于诊断不足以及影响伤害性反应的系统发生与衰老相关的变化,而无法获得疼痛缓解。未缓解的疼痛会引发行为症状,如躁动,这对这个脆弱的群体来说是一项艰巨的挑战。老年C57BL/6小鼠和淀粉样前体蛋白(APP)小鼠表现出的行为障碍类似于痴呆的行为和心理症状(BPSD)。因此,这项原创研究聚焦于衰老对伤害感受的影响,以深入了解BPSD的发生情况。我们研究了衰老如何影响C57BL/6小鼠在注射福尔马林后的伤害感受以及加巴喷丁的作用,因为加巴喷丁是慢性神经性疼痛的首选治疗药物之一。根据我们的研究结果,衰老过程中会出现对致痛刺激的伤害感受性行为变化。老年C57BL/6小鼠中福尔马林诱导的行为模式出现时间偏移且峰值幅度增加。我们的数据表明,加巴喷丁的有效性受动物年龄影响;尽管尚属初步,但这些数据为福尔马林试验诱导的长期机械性异常性疼痛可能是一种可靠的快速且可行的持续性疼痛模型提供了证据。所揭示的加巴喷丁有效性随年龄的差异可为深入研究老年人疼痛治疗奠定合理基础。